文献速递类风湿关节炎

类风湿关节炎研究中的又一Notch信号通路进展

Another Notch in the Belt of Rheumatoid Arthritis.
PubMed 文献 · Arthritis Rheumatol · 2024-08-09

本文综述Notch配体与受体在类风湿关节炎(RA)滑膜组织中的表达与调控:JAG1/2、DLL1/4及Notch1/3在RA巨噬细胞、成纤维样滑膜细胞和内皮细胞上富集,参与早期活动性RA尤其是新生血管形成,与影像学骨破坏无相关性;TNF是Notch表达的共同诱导因子,抗TNF应答良好者滑膜髓系细胞JAG1/2与DLL1/4转录下调;Notch阻断的小分子抑制剂在I、II期研究中失败。

要点

  • Notch家族在早期活动性RA中高表达并参与新生血管形成,与影像学骨破坏无相关性。
  • TNF是RA巨噬细胞、成纤维样滑膜细胞和内皮细胞Notch表达的共同诱导因子。
  • Notch阻断的小分子抑制剂在I、II期研究中失败,作者提示可能需要替代策略干预其功能。

核心结论

  • Notch家族在早期活动性RA中高度参与尤其新生血管形成,但不参与侵蚀期;Notch阻断的小分子抑制剂在I、II期研究中失败,提示可能需要替代策略来干预其功能。

研究设计与样本

  • 本文为综述,汇总Notch配体与受体在RA滑膜组织中的表达、调控及靶向干预研究。

主要发现

  • 与正常滑膜组织相比,JAG1/2、DLL1/4及Notch1/3在RA巨噬细胞、成纤维样滑膜细胞和/或内皮细胞上富集。
  • 能量多普勒超声引导的滑膜组织研究显示Notch家族高度参与早期活动性RA尤其新生血管形成,而与影像学损伤无相关性,不参与侵蚀期。
  • Toll样受体和TNF是RA巨噬细胞、成纤维样滑膜细胞和内皮细胞Notch表达的共同诱导因子;抗TNF应答良好者RA滑膜髓系细胞JAG1/2和DLL1/4转录下调。
  • 体外研究中TNF增加巨噬细胞Notch3表达,加入RA成纤维样滑膜细胞后进一步放大;特定改善病情抗风湿药降低巨噬细胞与RA成纤维样滑膜细胞共培养中JAG1和Notch3表达。
  • 含成纤维样滑膜细胞和内皮细胞的类器官JAG1和Notch3表达增加;甲氨蝶呤、IL-6R抗体和B细胞阻断剂大多不能降低Notch家族表达。

关键数值与推荐

  • NF-κB、MAPK和AKT通路参与Notch信号,而JAK/STATs不参与。
  • Notch阻断在RA临床前研究中有效,但其小分子抑制剂在I、II期研究中失败。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Notch ligands and receptors, including JAG1/2, DLL1/4, and Notch1/3, are enriched on macrophages (MΦs), fibroblast-like synoviocytes (FLS), and/or endothelial cells in rheumatoid arthritis (RA) compared with normal synovial tissues (ST). Power Doppler ultrasound-guided ST studies reveal that the Notch family is highly involved in early active RA, especially during neovascularization. In contrast, the Notch family is not implicated during the erosive stage, evidenced by their lack of correlation with radiographic damage in RA ST. Toll-like receptors and tumor necrosis factor (TNF) are the common inducers of Notch expression in RA MΦs, FLS, and endothelial cells. Among Notch ligands, JAG1 and/or DLL4 are most inducible by inflammatory responses in RA MΦs or endothelial cells and transactivate their receptors on RA FLS. TNF plays a central role on Notch ligands, as anti-TNF good responders display JAG1/2 and DLL1/4 transcriptional downregulation in RA ST myeloid cells. In in vitro studies, TNF increases Notch3 expression in MΦs, which is further amplified by RA FLS addition. Specific disease-modifying antirheumatic drugs reduced JAG1 and Notch3 expression in MΦ and RA FLS cocultures. Organoids containing FLS and endothelial cells have increased expression of JAG1 and Notch3. Nonetheless, Methotrexate, interleukin-6 receptor (IL-6R) antibodies, and B cell blockers are mostly ineffective at decreasing Notch family expression. NF-κB, MAPK, and AKT pathways are involved in Notch signaling, whereas JAK/STATs are not. Although Notch blockade has been effective in RA preclinical studies, its small molecule inhibitors have failed in phase I and II studies, suggesting that alternative strategies may be required to intercept their function.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Zack SR, Alzoubi O, Satoeya N, et al. Another Notch in the Belt of Rheumatoid Arthritis. Arthritis Rheumatol. 2024. PMID: 38961731. doi:10.1002/art.42937

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。